The largest database of trusted experimental protocols

Infinium human methylation 450k array

Manufactured by Illumina
Sourced in United States

The Infinium Human Methylation 450K array is a high-throughput DNA methylation profiling platform developed by Illumina. The array allows for the comprehensive analysis of DNA methylation patterns across the human genome, covering over 450,000 CpG sites. The core function of the Infinium Human Methylation 450K array is to provide a comprehensive assessment of the DNA methylation status at a large number of genomic regions in a single experiment.

Automatically generated - may contain errors

22 protocols using infinium human methylation 450k array

1

TCGA Methylation and Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TCGA methylation and expression data were downloaded from the University of Santa Cruz cancer browser – version 2015.
The 580 DNA methylation profiles were generated using Illumina’s Infinium Human Methylation 450k arrays. The 564 normalized RNA-seq v2 profiles were generated by IlluminaHiSeq. HPV status for 72 HPV+ and 243 HPV− samples was obtained from ref. [60 (link)].
+ Open protocol
+ Expand
2

TCGA Genome Data Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used open source data generated by TCGA genome data analysis centers [19 (link)]. Data on methylation 450K were downloaded from the TCGA Data Portal (https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp). Data on CNV and RNA expression were downloaded from the Broad genome data analysis center Firehose website (http://gdac.broadinstitute.org/). Data on RNA expression of XIST and clinical data were gathered using the CGDS-R package, which is a package of R for querying the Cancer Genomics Data Server and is hosted by the Computational Biology Center at Memorial-Sloan-Kettering Cancer Center [21 ]. The beta values for DNA methylation status were estimated using the Illumina Infinium Human Methylation 450K arrays. The beta value was calculated as an estimate of the ratio of intensities between methylated and unmethylated alleles. Segmented copy number was estimated by log2 of the ratio of total intensity of the tumor and the normal tissue using Affymetrix SNP6.0. Normalized RNA-Seq by expectation maximization (RSEM) were used as an estimate for mRNA expression [22 (link)]. Detailed information about the patients and experiment methods have been described elsewhere [19 (link)].
+ Open protocol
+ Expand
3

Genome-wide DNA Methylation Profiling in Biomedical Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genome-wide DNA methylation of isolated DNA samples in both cohorts (FHS and GOLDN) was measured using Infinium HumanMethylation450 K arrays (Illumina) as described (Absher et al., 2013 (link); Marioni et al., 2015 (link)). For FHS, DNA methylation data were requested from dbGaP (accession: phs000724.v9.p13). For both FHS and GOLDN, quality control (QC) processing was applied to the raw IDAT files as described (Morris et al., 2014 (link); Lai et al., 2018 (link)). To adjust for the heterogeneity of cell-type composition in the blood across samples, we calculated principal components (PCs) with β scores of all filtered autosomal DNA methylation sites (DMSs) using the PCA function implemented in SNP and VARIATION SUITE 8.9.0 (SVS 8.9.0, GoldenHelix Inc., Bozeman, MT, USA). The first five PCs were used as covariates to control for heterogeneity of different cell types in all analyses, which was well demonstrated in previous studies (Hidalgo et al., 2014 (link); Irvin et al., 2014 (link)). After QC, 415,202 DMSs remained and were included in this study. Among them, 76.7% (of total passing QC) of the CpGs were annotated as genic, whereas 23.8% of CpGs across the genome can be considered intergenic. Annotation was based on the human genome build GRCh37/hg19.
+ Open protocol
+ Expand
4

Comprehensive Genomic Analysis of GI Cancers

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 1696 GI cancer samples that were included in the final whitelist for TCGA (http://cancergenome.nih.gov) with clinical data and 1874 normal samples from GTEX (https://gtexportal.org/) were analyzed. The GSE73941 RNA-seq data were obtained from the GEO database. The TCGA data were first normalized and log2 transformed; GTEX data were normalized to TCGA. The somatic mutation data (amplification, deep deletion, and missense mutations) of GI cancers were downloaded from TCGA through cBioPortal and GISTIC [35] , [47] (link). Proteomic data were also taken from the TCGA database as normalized RPPA data through the cBioPortal. The value in the methylation profile represents the methylation degree calculated by Illumina Infinium Human Methylation 450K arrays through the DiseaseMeth version 2.0 [58] (link).
+ Open protocol
+ Expand
5

Genome-wide DNA Methylation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Illumina Infinium Human Methylation 450K arrays (Illumina, San Diego, California, USA) were used to determine genome-wide DNA methylation levels at approximately 485 000 CpG sites of blood taken at the baseline visit. We randomised 1656 LifeLines subjects based on sex, exposure and airway obstruction across the arrays. Using 500 ng DNA for each sample, we first performed a bisulphite conversion using the EZ-96 DNA methylation kit (Zymo Research, Irvine, California, USA), which was validated using commercially available bisulphite conversion control samples (Zymo Research). After this step, the samples were processed according to the Illumina 450K protocol. After quality control, the final data set contained data for 1561 subjects and 420 938 CpG probes (see online supplementary methods for quality control).
+ Open protocol
+ Expand
6

DNA Methylation Profiling with Infinium Arrays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA (approximately 500 ng) was bisulfite converted using EZ DNA Methylation Kit (Zymo Research Corp. Irvine, CA, USA) following the manufacturer’s protocol. Bisulfite converted DNA materials were then processed and hybridized to the Infinium Human Methylation 450 k arrays (Illumina, San Diego, CA, USA) according to manufacturer’s recommendation. Preprocessing and initial quality assessments of the raw data were examined using the following R packages. Subset-quantile within-array normalization (SWAN) [29 (link)] was used to normalize raw methylation values. IlluminaHumanMethylation450k.db annotation package was used to annotate the CpG probes location. Probe sets with a beta value above 0.3 were taken as methylated [30 (link), 31 (link)]. Before any genomic and statistical analyses were conducted, we normalized and inspected the methylation data for the presence of substantial confounding batch effects. Cellular deconvolution analyses were carried out using estimated cellular fractions using MethylCIBERSORT [32 (link)].
+ Open protocol
+ Expand
7

Epigenome-wide DNA Methylation Analysis of Ischemic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve cases and 12 controls were selected from cohort 1 for epigenome-wide association analysis according to the following inclusion criteria: (1) age from 65 to 75 years; (2) no smoking and no drinking; and (3) matched sex, hypertension, and diabetes mellitus status (Table I in the online-only Data Supplement). Illumina Infinium HumanMethylation450K arrays (Illumina, San Diego, CA) were used to determine genome-wide DNA methylation levels at ≈485 000 CpG sites. Using 500 ng of DNA per sample, we first performed a bisulfite conversion using the EZ-96 DNA methylation kit (Zymo Research, Irvine, CA). Then, the genome-wide methylation profiles were assessed using the Illumina 450K BeadChip assay according to the manufacturer's standard procedure. Raw methylation matrices were then normalized using the dasen method in the wateRmelon package. 19 (link) General linear regression was used to determine whether there was a significant difference in methylation between IS cases and controls; the dependent variable was DNA methylation levels at each site, and the independent variables included stroke (case=1, control=0), age, and sex. The methylation data were then filtered using significance thresholds based on a P<0.01 and |methylation change|>5%.
+ Open protocol
+ Expand
8

Methylation-based Breast Cancer Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Cancer Genome Atlas (TCGA) data for Breast Invasive Carcinoma (BRCA) cohort were extracted from the TCGA data portal via the UCSC Cancer Genome Browser (https://xena.ucsc.edu/welcome-to-ucsc-xena/).
In order to evaluate the methylation status of the hTERT hypermethylated oncologic region (THOR), level 3 methylation data derived from the Illumina Infinium HumanMethylation450K array was assessed in BRCA cohort (normal tissue, n = 98 and primary tumor n = 743). The methylation status of the probe cg11625005 (chr5:1,295,737, GRCh37/hg19 genome assembly), which targets a CpG site within THOR region was analyzed. DNA methylation status is presented as beta-values (β values) ranging from 0 to 1, which corresponds to unmethylated and completely methylated DNA, respectively.
The specificity and sensitivity of methylation levels for breast cancer diagnosis were evaluated by receiver operating characteristic (ROC) curve analysis [35 (link)] with diagnostic validity suggested by an area under the ROC curve (AUC) ≥ 0.8.
hTERT gene expression data was derived from Illumina HiSeq 2000 RNA Sequencing (normal tissue, n = 85 and primary tumor, n = 742). This dataset includes gene-level transcription estimates, as in log2 [x + 1] transformed RNA-Seq by Expectation Maximization (RSEM) normalized count.
+ Open protocol
+ Expand
9

DNA Methylation Profiling of Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used Illumina Infinium Human Methylation 450K array to quantify DNA methylation levels across the genome from whole blood in RS. The detailed QC and normalization criteria can be found in the Supplementary Material. Ultimately, after the QC and normalization steps our discovery set included 724 Caucasian participants and 463 456 probes, while the replication set included 766 Caucasian participants and 419 936 probes.
+ Open protocol
+ Expand
10

DNA Methylation Profiling Using Illumina 450K Array

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA methylation levels in whole blood were determined using the Illumina Infinium Human Methylation 450K Array. After quality control, DNA methylation data presented as beta values were available for 420 938 CpG sites.8 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!